Command Palette

Search for a command to run...

Clinical Trials · NCT01722227

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

WithdrawnPhase 3Liraglutide (Prohibited)
Phase
Phase 3
Recruitment status
Withdrawn
Sponsor
University at Buffalo
Enrollment
0
Start date
Nov 2012
Locations
1 site, United States
Primary endpoint
Mean weekly blood glucose concentrations.
View Liraglutide compound reference